Orkla confirms intention to list Borregaard ASA on the Oslo Stock Exchange
9/19/2012 3:03 AM EST
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR
INDIRECTLY, TO U.S. NEWS WIRE
SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AUSTRALIA, CANADA OR JAPAN,
OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION
OR RELEASE WOULD BE
UNLAWFUL.
Orkla ASA (OSE:ORK) confirms its intention to proceed
with an Initial Public
Offering ("the Offering") of the shares in Borregaard
ASA (BRG). An application
was filed with the Oslo Stock Exchange on 28 August
2012 for the shares of
Borregaard to be admitted to the main list on the
Oslo Stock Exchange. Subject
to the relevant approvals from the Oslo Stock
Exchange and to market conditions,
the Offering is expected to price during the fourth
quarter 2012. The Offering
is planned to comprise existing shares being sold by
Orkla. The shares will be
offered to institutional investors in Norway and
internationally and in a retail
offering to the public in Norway. Pre-marketing of
the Offering will start
today, September 19.
ABG Sundal Collier Norge ASA and UBS Limited are
acting as Joint Global Co-
ordinators and Joint Bookrunners, and DNB Markets (a
part of DNB Bank ASA),
Handelsbanken Capital Markets (a part of Svenska
Handelsbanken AB (publ.)) and
SEB Enskilda (a part of Skandinaviska Enskilda Banken
AB (publ.)) are acting as
Co-Lead Managers.
Further announcements relating to the Offering will
be made in due course.
For further queries, please contact:
Håkon Mageli, EVP Corporate Communications and
Corporate Affairs
Tel: +47 92 84 58 28
Anders Kalleberg, Investor Relations
Tel: +47 99 04 24 98
ABOUT BORREGAARD
Borregaard is a bio-based specialty chemicals company
with one of the world's
most advanced biorefineries. From natural and
renewable raw materials,
Borregaard produces advanced and environmentally
friendly biochemicals,
biomaterials and bioethanol that can be used as
substitutes for petrochemical-
based products. Borregaard also holds strong
positions within ingredients and
fine chemicals. Borregaard has 1100 employees in
plants and sales offices in 17
countries throughout Europe, the Americas, Asia and
Africa.
DISCLAIMERS
These materials are not an offer for sale of
securities.
Copies of this announcement are not being made and
may not be distributed or
sent into the United States, Australia, Canada, Japan
or any other jurisdiction
in which such distribution would be unlawful or would
require registration or
other measures.
The securities have not been registered under the
U.S. Securities Act of 1933,
as amended (the "Securities Act"), and may not be
offered or sold in the United
States absent registration or an exemption from the
registration requirements of
the Securities Act. The Company does not intend to
register any part of the
offering in the United States or to conduct a public
offering of securities in
the United States.
Any offering of securities will be made by means of a
prospectus that may be
obtained from the issuer or selling security holder
and that will contain
detailed information about the Company and
management, as well as financial
statements. This document is an advertisement and not
a prospectus for the
purposes of Directive 2003/71/EC (together with any
applicable implementing
measures in any Member State, the "Prospectus
Directive"). Investors should not
subscribe for any securities referred to in this
document except on the basis of
information contained in the prospectus.
In any EEA Member State other than Norway that has
implemented the Prospectus
Directive, this communication is only addressed to
and is only directed at
qualified investors in that Member State within the
meaning of the Prospectus
Directive, i.e., only to investors who can receive
the offer without an approved
prospectus in such EEA Member State.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR
INDIRECTLY, TO U.S. NEWS WIRE
SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AUSTRALIA, CANADA OR JAPAN,
OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION
OR RELEASE WOULD BE
UNLAWFUL.
This communication is only being distributed to and
is only directed at (i)
persons who are outside the United Kingdom or (ii) to
investment professionals
falling within Article 19(5) of the Financial
Services and Markets Act 2000
(Financial Promotion) Order 2005 (the "Order") or
(iii) above together being
referred to as "relevant persons"). The securities
are only available to, and
any invitation, offer or agreement to subscribe,
purchase or otherwise acquire
such securities will be engaged in only with,
relevant persons. Any person who
is not a relevant person should not act or rely on
this document or any of its
contents. Stabilization/FSA
Matters discussed in this release may constitute
forward-looking statements.
Forward-looking statements are statements that are
not historical facts and may
be identified by words such
as "believe," "expect," "anticipate," "intends,"
"estimate," "will," "may," "continue," "should" and
similar expressions. The
forward-looking statements in this release are based
upon various assumptions,
many of which are based, in turn, upon further
assumptions. Although the
Company believes that these assumptions were
reasonable when made, these
assumptions are inherently subject to significant
known and unknown risks,
uncertainties, contingencies and other important
factors which are difficult or
impossible to predict and are beyond its control.
Such risks, uncertainties,
contingencies and other important factors could cause
actual events to differ
materially from the expectations expressed or implied
in this release by such
forward-looking statements.
The information, opinions and forward-looking
statements contained in this
release speak only as at its date, and are subject to
change without notice.
This information is subject of the disclosure
requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.